Carerx Corp Stock Debt To Equity
| CRRX Stock | CAD 2.75 0.01 0.36% |
CareRx Corp fundamentals help investors to digest information that contributes to CareRx Corp's financial success or failures. It also enables traders to predict the movement of CareRx Stock. The fundamental analysis module provides a way to measure CareRx Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareRx Corp stock.
| Last Reported | Projected for Next Year | ||
| Debt To Equity | 0.98 | 0.93 |
CareRx | Debt To Equity |
CareRx Corp Company Debt To Equity Analysis
CareRx Corp's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current CareRx Corp Debt To Equity | 2.35 % |
Most of CareRx Corp's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CareRx Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CareRx Debt To Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for CareRx Corp is extremely important. It helps to project a fair market value of CareRx Stock properly, considering its historical fundamentals such as Debt To Equity. Since CareRx Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CareRx Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CareRx Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
CareRx Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, CareRx Corp has a Debt To Equity of 2.35%. This is 95.61% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The debt to equity for all Canada stocks is 95.17% higher than that of the company.
CareRx Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CareRx Corp's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CareRx Corp could also be used in its relative valuation, which is a method of valuing CareRx Corp by comparing valuation metrics of similar companies.CareRx Corp is currently under evaluation in debt to equity category among its peers.
CareRx Fundamentals
| Return On Equity | -0.0543 | ||||
| Return On Asset | 0.0186 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 244.47 M | ||||
| Shares Outstanding | 62.15 M | ||||
| Shares Owned By Insiders | 10.35 % | ||||
| Shares Owned By Institutions | 28.05 % | ||||
| Number Of Shares Shorted | 26.34 K | ||||
| Price To Book | 2.03 X | ||||
| Price To Sales | 0.47 X | ||||
| Revenue | 366.71 M | ||||
| Gross Profit | 108.06 M | ||||
| EBITDA | 22.06 M | ||||
| Net Income | (4.5 M) | ||||
| Cash And Equivalents | 28.37 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 5.33 M | ||||
| Debt To Equity | 2.35 % | ||||
| Current Ratio | 1.69 X | ||||
| Book Value Per Share | 1.35 X | ||||
| Cash Flow From Operations | 37.99 M | ||||
| Short Ratio | 1.53 X | ||||
| Earnings Per Share | (0.07) X | ||||
| Target Price | 3.73 | ||||
| Number Of Employees | 1.42 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 171.55 M | ||||
| Total Asset | 223.54 M | ||||
| Retained Earnings | (287.19 M) | ||||
| Working Capital | (467 K) | ||||
| Net Asset | 223.54 M |
About CareRx Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareRx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in CareRx Stock
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.